Zenocutuzumab Uses, Dosage, Side Effects and more
Zenocutuzumab is under investigation in clinical trial NCT03321981 (MCLA-128 With Trastuzumab/chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer).
| Trade Name | Zenocutuzumab |
| Generic | Zenocutuzumab |
| Zenocutuzumab Other Names | Zenocutuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
